115 related articles for article (PubMed ID: 11180193)
1. Pharmacokinetics and tissue distribution of ipriflavone, an isoflavone derivative, after intravenous administration to rabbits.
Kim S; Lee J; Lee M
Biopharm Drug Dispos; 2000 May; 21(4):147-56. PubMed ID: 11180193
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects.
Kim SH; Lee MG
Life Sci; 2002 Feb; 70(11):1299-315. PubMed ID: 11883708
[TBL] [Abstract][Full Text] [Related]
3. Determination of a isoflavone derivative, ipriflavone, and its metabolites, M1 and M5, in rat plasma, urine, and tissue homogenate by high-performance liquid chromatography.
Kim SH; Lee JS; Lee MG
Res Commun Mol Pathol Pharmacol; 1997 Dec; 98(3):313-24. PubMed ID: 9485525
[TBL] [Abstract][Full Text] [Related]
4. Effects of E. Coli lipopolysaccharide on the pharmacokinetics of ipriflavone and its metabolites, M1 and M5, after intravenous and oral administration of ipriflavone to rats: decreased metabolism of ipriflavone due to decreased expression of hepatic CYP1A2 and 2C11.
Chung HJ; Kang HE; Bae EJ; Lee I; Kim SG; Lee MG
J Pharm Sci; 2008 Nov; 97(11):5024-36. PubMed ID: 18314883
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of ipriflavone and its two metabolites, M1 and M5, after the intravenous and oral administration of ipriflavone to rat model of diabetes mellitus induced by streptozotocin.
Lee DY; Chung HJ; Choi YH; Lee U; Kim SH; Lee I; Lee MG
Eur J Pharm Sci; 2009 Dec; 38(5):465-71. PubMed ID: 19761842
[TBL] [Abstract][Full Text] [Related]
6. Integrated pharmacokinetic and metabolic modeling of ipriflavone and metabolites after oral administration.
Rohatagi S; Barrett JS
Am J Ther; 1997; 4(5-6):189-98. PubMed ID: 10423610
[TBL] [Abstract][Full Text] [Related]
7. Stability, blood partition and plasma protein binding of ipriflavone, an isoflavone derivative.
Kim SH; Lee JS; Lee MG
Biopharm Drug Dispos; 1999 Oct; 20(7):355-60. PubMed ID: 10760844
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic changes of ipriflavone in rats with acute renal failure induced by uranyl nitrate.
Chung HJ; Lee MG
Biopharm Drug Dispos; 2006 Oct; 27(7):345-51. PubMed ID: 16902944
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats.
Yoon WH; Park SJ; Kim IC; Lee MG
Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):227-40. PubMed ID: 9226757
[TBL] [Abstract][Full Text] [Related]
10. [Metabolism of ipriflavone].
Ferenc L; István S
Acta Pharm Hung; 1995 Nov; 65(6):215-8. PubMed ID: 8742628
[TBL] [Abstract][Full Text] [Related]
11. Characterization of cytochrome P450s mediating ipriflavone metabolism in human liver microsomes.
Moon Y; Kim SY; Ji HY; Kim YK; Chae HJ; Chae SW; Lee HS
Xenobiotica; 2007 Mar; 37(3):246-59. PubMed ID: 17624023
[TBL] [Abstract][Full Text] [Related]
12. Effects of water deprivation for 72 h on the pharmacokinetics of ipriflavone in rats.
Chung HJ; Lee I; Lee MG
Res Vet Sci; 2008 Aug; 85(1):149-55. PubMed ID: 17919668
[TBL] [Abstract][Full Text] [Related]
13. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of ipriflavone and metabolites after oral administration of a corn-oil suspension relative to the Osteofix tablet.
Rohatagi S; Barrett JS; Sawyers W; Yu K; Morales RJ
Am J Ther; 1997; 4(7-8):229-38. PubMed ID: 10423615
[TBL] [Abstract][Full Text] [Related]
15. Comparative bioavailability of two oral formulations of ipriflavone in healthy volunteers at steady-state. Evaluation of two different dosage schemes.
Acerbi D; Poli G; Ventura P
Eur J Drug Metab Pharmacokinet; 1998; 23(2):172-7. PubMed ID: 9725477
[TBL] [Abstract][Full Text] [Related]
16. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous ipriflavone in rats.
Chung HJ; Choi YH; Kim SH; Lee MG
J Pharm Pharmacol; 2006 Apr; 58(4):449-57. PubMed ID: 16597362
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetics of ipriflavone].
Ferenc L; István S
Acta Pharm Hung; 1995 Nov; 65(6):219-22. PubMed ID: 8742629
[TBL] [Abstract][Full Text] [Related]
18. Ipriflavone pharmacokinetics in mutant Nagase analbuminemic rats.
Chung HJ; Kang HE; Yang KH; Kim SY; Lee MG
Biopharm Drug Dispos; 2009 Sep; 30(6):294-304. PubMed ID: 19591122
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of methotrexate after intravenous and intramuscular injection of methotrexate-bearing positively charged liposomes to rats.
Kim MM; Lee SH; Lee MG; Hwang SJ; Kim CK
Biopharm Drug Dispos; 1995 May; 16(4):279-93. PubMed ID: 7548777
[TBL] [Abstract][Full Text] [Related]
20. Steady-state pharmacokinetics of ipriflavone and its metabolites in patients with renal failure.
Rondelli I; Acerbi D; Ventura P
Int J Clin Pharmacol Res; 1991; 11(4):183-92. PubMed ID: 1813437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
